Assembly Biosciences Inc Cash Flow-to-Debt Ratio
Assembly Biosciences Inc cash flow-to-debt ratio. Assembly Biosciences Inc (ASMB) has a Cash Flow-to-Debt Ratio of -0.62x as of June 2026, meaning its operating cash flow of $-15.49 Million could theoretically repay -1% of its total liabilities ($25.18 Million) in one year. Check Assembly Biosciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Assembly Biosciences Inc (2008–2025)
Cash flow-to-debt ratio of Assembly Biosciences Inc from 2008 to 2025. Historical debt coverage capacity for Assembly Biosciences Inc across 18 annual periods. Check ASMB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Assembly Biosciences Inc Cash Flow-to-Debt Ratio by Year (2008–2025)
Assembly Biosciences Inc cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Assembly Biosciences Inc. For the full cash flow conversion analysis, see ASMB cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.81x | $-41.09 Million | $50.84 Million | ▼ -35.7% |
| 2024 | -0.60x | $-51.12 Million | $85.81 Million | ▼ -350.7% |
| 2023 | 0.24x | $22.74 Million | $95.73 Million | ▲ +105.4% |
| 2022 | -4.42x | $-84.46 Million | $19.13 Million | ▼ -4.6% |
| 2021 | -4.22x | $-93.40 Million | $22.13 Million | ▼ -186.1% |
| 2020 | -1.48x | $-62.96 Million | $42.68 Million | ▼ -31.0% |
| 2019 | -1.13x | $-84.07 Million | $74.67 Million | ▲ +0.5% |
| 2018 | -1.13x | $-64.96 Million | $57.39 Million | ▼ -3518.7% |
| 2017 | 0.03x | $1.86 Million | $56.18 Million | ▲ +101.7% |
| 2016 | -1.91x | $-34.88 Million | $18.24 Million | ▼ -53.4% |
| 2015 | -1.25x | $-18.70 Million | $15.00 Million | ▼ -5.3% |
| 2014 | -1.18x | $-14.97 Million | $12.65 Million | ▲ +82.5% |
| 2013 | -6.75x | $-17.80 Million | $2.64 Million | ▲ +13.4% |
| 2012 | -7.79x | $-21.38 Million | $2.75 Million | ▲ +21.9% |
| 2011 | -9.98x | $-25.07 Million | $2.51 Million | ▼ -472.1% |
| 2010 | -1.74x | $-5.21 Million | $2.99 Million | ▼ -577.1% |
| 2009 | -0.26x | $-3.48 Million | $13.53 Million | ▲ +35.9% |
| 2008 | -0.40x | $-4.15 Million | $10.33 Million | — |